NCT07282236

Brief Summary

Objective: compare outcomes of unstable intertrochanteric hip fractures treated with two commercially available implants. Design: retrospective observational cohort of 288 treated with a Gamma® nail and 398 with an InterTAN® nail. Patients were operated between 1997 and 2010. Primary outcomes: satisfactory reduction, optimal cephalic screw placement, and to evaluate the incidence of mechanical complications; secondary measures included the tip-apex distance (TAD), hematocrit (Hto) and hemoglobin (Hb) drop, transfusion requirement and volume, hospital length of stay and the time to first ambulation.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
686

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2025

Completed
22 days until next milestone

Study Start

First participant enrolled

December 13, 2025

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 15, 2025

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2026

Completed
Last Updated

January 13, 2026

Status Verified

October 1, 2025

Enrollment Period

1 month

First QC Date

November 21, 2025

Last Update Submit

January 12, 2026

Conditions

Keywords

Throchanteric Fractures; Gamma nail; InterTAN nail

Outcome Measures

Primary Outcomes (1)

  • Implant-related complications

    Incidence of device-related adverse events (e.g., cut-out, varus collapse).

    6 months

Secondary Outcomes (2)

  • Quality of fracture reduction

    Immediately postoperative (within 24 hours)

  • Cephalic screw placement

    Immediately postoperative (within 24 hours)

Study Arms (2)

Gamma Nail Group

The Gamma Nail Group consists of patients diagnosed with unstable trochanteric fractures who underwent surgical management using a Gamma cephalomedullary nail. This intervention involves internal fixation with a short or long intramedullary device designed to provide stable biomechanical support for unstable peritrochanteric fracture patterns. Patients in this group received the Gamma nail as the primary method of fracture stabilization, with the goal of achieving early mobilization, maintaining fracture alignment, and reducing the risk of mechanical complication.

Device: Fracture fixation with cephalomedullary nails

InterTAN Nail Group

The InterTAN Nail Group includes patients with unstable trochanteric fractures who were treated surgically using an InterTAN cephalomedullary nail. This intervention consists of internal fixation with a dual integrated screw intramedullary device designed to enhance rotational and axial stability in unstable peritrochanteric fracture patterns. Patients in this group received the InterTAN nail as the primary method of fracture stabilization, aiming to improve construct rigidity, facilitate early mobilization, and support optimal fracture healing.

Device: Fracture fixation with cephalomedullary nails

Interventions

No differences with the routine surgery for trochanteric fractures

Gamma Nail GroupInterTAN Nail Group

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who received the Gamma nail (288) underwent surgery at the Hospital Clínico Universitario, Valencia (1997-2002). On the other hand, the patients operated upon the InterTAN nail (398) underwent surgery at the Vithas Hospitals Group in Valencia between January 2002 and December 2010.

You may qualify if:

  • Unstable trochanteric fractures confirmed radiographically according to OTA (Orthopedic Trauma Association), treated with Gamma or InterTAN nail,
  • available follow-up for ≥ 6 months

You may not qualify if:

  • Pathological fractures
  • Polytrauma precluding standard treatment/follow-up
  • Missing key variables/outcomes

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

School of Medicine and Health Sciences, Valencia Catholic University

Valencia, VALÈNCIA, 46003, Spain

Location

Related Publications (4)

  • Núñez JH, Moreira F, Surroca M, Martínez-Peña J, Jiménez-Jiménez MJ, Ocrospoma-Flores B, Castillón P, Guerra-Farfán E. Hip fractures in Spain. How are we? Systematic review and meta-analysis of the published registries. Rev Esp Cir Ortop Traumatol. 2024 Oct 16:S1888-4415(24)00156-5. English, Spanish. doi: 10.1016/j.recot.2024.09.010. Epub ahead of print. PMID: 39419269.

    RESULT
  • Werner M, Macke C, Gogol M, Krettek C, Liodakis E. Differences in hip fracture care in Europe: a systematic review of recent annual reports of hip fracture registries. Eur J Trauma Emerg Surg. 2022 Jun;48(3):1625-1638. doi: 10.1007/s00068-021-01797-8. Epub 2021 Oct 8.

  • Shankar KN, Li A. Older Adult Falls in Emergency Medicine, 2023 Update. Clin Geriatr Med. 2023 Nov;39(4):503-518. doi: 10.1016/j.cger.2023.05.010. Epub 2023 Jul 6.

  • Kalan Farmanfarma K, Yarmohammadi S, Fakharian E, Gobbens RJ, Mahdian M, Batooli Z, Lotfi MS, Abedzadeh-Kalahroudi M, Vatan RF, Khosravi GR, Fazel MR, Sehat M. Prognostic Factors of Hip Fracture in Elderly: A Systematic Review. Int J Prev Med. 2024 Aug 30;15:42. doi: 10.4103/ijpvm.ijpvm_169_23. eCollection 2024.

MeSH Terms

Interventions

Fracture Fixation

Intervention Hierarchy (Ancestors)

Orthopedic ProceduresTherapeuticsSurgical Procedures, Operative

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 21, 2025

First Posted

December 15, 2025

Study Start

December 13, 2025

Primary Completion

January 12, 2026

Study Completion

January 12, 2026

Last Updated

January 13, 2026

Record last verified: 2025-10

Locations